These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6147789)
21. A controlled clinical trial of alprazolam for the treatment of anxiety. Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927 [TBL] [Abstract][Full Text] [Related]
22. Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients. Christensen I; Geismar L; Kirkegaard A; Kirkegaard G Arzneimittelforschung; 1986 May; 36(5):855-60. PubMed ID: 2873821 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
24. Low doses of ketazolam in anxiety: a double-blind, placebo-controlled study. Scarpini E; Baron PG; Bet L; Bottini G; Bresolin N; Meola G; Pezzoli G; Vallar G; Monza GC; Scarlato G Neuropsychobiology; 1988; 20(2):74-7. PubMed ID: 2908133 [TBL] [Abstract][Full Text] [Related]
26. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734 [TBL] [Abstract][Full Text] [Related]
27. The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia. Sumiyoshi T; Jayathilake K; Meltzer HY Schizophr Res; 2003 Jan; 59(1):7-16. PubMed ID: 12413636 [TBL] [Abstract][Full Text] [Related]
28. Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial. Rickels K; Mathew S; Banov MD; Zimbroff DL; Oshana S; Parsons EC; Donahue SR; Kauffman M; Iyer GR; Reinhard JF J Clin Psychopharmacol; 2008 Apr; 28(2):235-9. PubMed ID: 18344738 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam]. Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC Encephale; 1984; 10(3):135-8. PubMed ID: 6389091 [TBL] [Abstract][Full Text] [Related]
30. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial. Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097 [TBL] [Abstract][Full Text] [Related]
31. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients. Cohn JB J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853 [TBL] [Abstract][Full Text] [Related]
32. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Hanus M; Lafon J; Mathieu M Curr Med Res Opin; 2004 Jan; 20(1):63-71. PubMed ID: 14741074 [TBL] [Abstract][Full Text] [Related]
33. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044 [TBL] [Abstract][Full Text] [Related]
34. Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients. Kirkegaard A; Kirkegaard G; Geismar L; Christensen I Arzneimittelforschung; 1981; 31(4):737-40. PubMed ID: 6113835 [TBL] [Abstract][Full Text] [Related]
35. A double-blind, placebo-controlled study of alpidem, a novel anxiolytic of imidazopyridine structure, in chronically anxious patients. Casacchia M; Farolfi A; Priore P; Magni G; Stratta P; Cesana B; Rossi A Acta Psychiatr Scand; 1989 Aug; 80(2):137-41. PubMed ID: 2572145 [TBL] [Abstract][Full Text] [Related]
36. Anxiolytic efficacy of alprazolam compared to diazepam and placebo. Maletzky BM J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940 [TBL] [Abstract][Full Text] [Related]
37. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder. Alpert JE; Franznick DA; Hollander SB; Fava M J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591 [TBL] [Abstract][Full Text] [Related]
38. Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey. Hefner G; Unterecker S; Shams ME; Wolf M; Falter T; Haen E; Hiemke C J Neural Transm (Vienna); 2015 Nov; 122(11):1609-17. PubMed ID: 25940834 [TBL] [Abstract][Full Text] [Related]
39. Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients. Bassi S; Albizzati MG; Ferrarese C; Frattola L; Cesana B; Piolti R; Farolfi A Clin Neuropharmacol; 1989 Feb; 12(1):67-74. PubMed ID: 2565767 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline. Guelfi JD; Pichot P; Dreyfus JF Neuropsychobiology; 1989; 22(1):41-8. PubMed ID: 2700774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]